Skip to content

Addiction: all studies

Page 702 of 855: studies 7,011 to 7,020 of 8,547, newest first. Back to the addiction overview

Research

Mindfulness and modification therapy for behavioral dysregulation: results from a pilot study targeting alcohol use and aggression in women.

Journal of Clinical Psychology September 19, 2011 Peggilee Wupperman, G Alan Marlatt, Amy Cunningham et al.

Objectives: Increasing evidence suggests that deficits in mindfulness (awareness, attentiveness, and acceptance of the present moment) play a role in a range of disorders involving behavioral dysregulation. This paper adds to that literature by describing a transdiagnostic psychotherapy (Mindfulness & Modification Therapy; MMT) developed to target behavioral dysregulation. Design: An...

DOI: 10.1002/jclp.20830 (opens in new tab) Full text (opens in new tab) Humans Alcoholism Treatment outcome Pilot projects +9

Effects of quetiapine and sertindole on subchronic ketamine-induced deficits in attentional set-shifting in rats.

Psychopharmacology September 15, 2011 Agnieszka Nikiforuk, Piotr Popik

Rationale: Prefrontal cortical dysfunctions, including an impaired ability to shift perceptual attentional set, are core features of schizophrenia. Nevertheless, the effectiveness of second-generation antipsychotic drugs in treating specific prefrontal dysfunctions remains equivocal. Objectives: To model schizophrenia-like cognitive inflexibility in rats, we evaluated the effects of repeated...

DOI: 10.1007/s00213-011-2487-x (opens in new tab) Full text (opens in new tab) Ketamine Animals Rats, sprague-dawley Disease models, animal +10

Pills and pints: Risky drinking and alcohol‐related harms among regular ecstasy users in Australia

Drug and Alcohol Review September 15, 2011 Stuart A. Kinner, Jessica George, Jennifer M. Johnston et al. 19 citations

INTRODUCTION AND AIMS: A significant proportion of young Australians engage in risky alcohol consumption, and an increasing minority are regular ecstasy (3,4-methylenedioxymethamphetamine) users. Risky alcohol use, alone or in combination with ecstasy, is associated with a range of acute and chronic health risks. The aim of this study was to document the incidence and some health-related...

Neuropsychological deficits associated with cannabis use in young adults

Drug and Alcohol Dependence September 14, 2011 J. Grant, S. Chamberlain, Liana R. N. Schreiber et al.

Background Cannabis is the most widely used illicit substance and has been associated with cognitive impairment. It is unclear whether such impairment can occur in the absence of potential confounding influences of co-morbid axis-I disorders and use of other illicit substances. Method Young adult volunteers (18–29 years) were recruited from the general community on the basis of having no axis-I...

The relationships of ‘ecstasy’ (MDMA) and cannabis use to impaired executive inhibition and access to semantic long‐term memory

Human Psychopharmacology Clinical and Experimental September 7, 2011 Philip N. Murphy, Philip G. Erwin, L. Maciver et al. 9 citations

This study aimed to examine the relationship between the consumption of ecstasy (3,4-methylenedioxymethamphetamine (MDMA)) and cannabis, and performance on the random letter generation task which generates dependent variables drawing upon executive inhibition and access to semantic long-term memory (LTM). The participant group was a between-participant independent variable with users of both...

Yoga and Change: The Power of Partnership 1: Yoga, Public Health, and the Problem of Getting Noticed 2: Mindfulness, Meditation and Yoga: Competition or Collaboration? 3

International Journal of Yoga Therapy September 1, 2011 Molly Lannon Kenny, Staffan Elgelid, Bidyut Bose 1 citation

By July of 2000, I was done with my job as a clinician. Having worked for over six years as a speech-language pathologist at one of the country's largest HMOs, I felt burned out, turned off, and depleted. It wasn't that I didn't like the work—I did. In fact, I loved the opportunity to come into people's lives and help them with whatever life challenges brought them to my office. What I had...

Reaching out towards cannabis: approach-bias in heavy cannabis users predicts changes in cannabis use

Addiction September 1, 2011 J. Cousijn, A. Goudriaan, R. Wiers

Aims Repeated drug exposure can lead to an approach-bias, i.e. the relatively automatically triggered tendencies to approach rather that avoid drug-related stimuli. Our main aim was to study this approach-bias in heavy cannabis users with the newly developed cannabis Approach Avoidance Task (cannabis-AAT) and to investigate the predictive relationship between an approach-bias for...

Abuse potential and psychoactive effects of δ-9-tetrahydrocannabinol and cannabidiol oromucosal spray (Sativex), a new cannabinoid medicine.

Expert Opinion on Drug Safety September 2011 Philip Robson

There is a growing consensus that cannabis dependence is a substantial and underappreciated problem. The key component responsible for the euphoric effects of cannabis and its dependence potential is δ-9-tetrahydrocannabinol (THC). THC-containing cannabinoid medicines theoretically pose a risk of abuse and dependence. In order to evaluate the potential of Sativex to cause cannabis-like...

THC-methadone and THC-naltrexone interactions on discrimination, antinociception, and locomotion in rats.

Behavioural Pharmacology September 2011 Alexa A Wakley, Rebecca M Craft

This study examined cannabinoid-opioid interactions within the same subjects on measures of discrimination, antinociception, horizontal locomotion, and catalepsy. Male Sprague-Dawley rats were trained to discriminate Δ(9)-tetrahydrocannabinol (THC, 3 mg/kg) from vehicle. THC alone (0.32-10 mg/kg) dose-dependently increased THC-appropriate lever responding and decreased response rate. THC alone...

GHB and synthetic cathinones: clinical effects and potential consequences.

Drug Testing and Analysis September 2011 Laurent Karila, Michel Reynaud

Designer drugs belong to a group of legally or illegally produced substances that are structurally and pharmacologically very similar to illicit drugs. In the past, designer drugs were often used during all-night dance parties, but they are now consumed in multiple settings from college bars to parks to private house parties. Most of these club drugs can be bought on legal websites and...